United States of America based
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas.
Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990, has over 400 employees, and is engaged with customers and collaborators in more than 70 countries
TechnologiesAI Companies (Drug Discovery) Pharmaceutical and Drug Discovery Quantum Theory in Drug Discovery
Posts Mentioning This Company
Docking/fitting prediction, a range of computational chemistry tools, new to DL
Our world-class drug discovery team is leveraging our computational platform and massive computing power to advance our preclinical pipeline and a portfolio of programs in collaboration with leading biotech and pharmaceutical companies.
No services posted yet